C 
3.94
+0.51%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Net income
−$15.9m
FY2017FY2025
Free cash flow
−$13.8m
FY2017FY2025
Shareholders' equity
$4.5m
FY2017FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Gross profit | — | −$3,306 | −$4,134 | −$11,756 | −$13,070 | −$11,096 | −$1,955 | — | — |
| Research and development | $9.8m | $9.3m | $14.1m | $9.3m | $9.8m | $5.1m | $1.9m | $21,267 | $32,638 |
| Operating income | −$16.0m | −$14.9m | −$18.9m | −$14.9m | −$14.5m | −$9.5m | −$3.8m | −$881,787 | −$516,252 |
| Net income | −$15.9m | −$14.9m | −$18.9m | −$15.3m | −$14.5m | −$9.5m | −$3.9m | −$7.4m | −$526,469 |
| Diluted earnings per share | -35.75 | -126.13 | -7,540.49 | — | — | — | — | — | -0.08 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $8.6m | $8.7m | $1.7m | $13.1m | $8.8m | $15.9m | $7.9m | $683,333 | $162,194 |
| Cash and short-term investments | $7.2m | $6.5m | $548,721 | $10.1m | $5.0m | $14.0m | $7.2m | $282,736 | $110,543 |
| Total liabilities | $4.1m | $2.5m | $6.1m | $4.9m | $2.1m | $1.9m | $311,000 | $1.2m | $220,726 |
| Debt | $328,571 | $326,072 | $300,806 | $409,968 | $387,794 | $439,294 | — | $316,918 | $121,825 |
| Shareholders' equity | $4.5m | $6.2m | −$4.4m | $8.1m | $6.6m | $13.9m | $7.6m | −$549,298 | −$58,532 |
| Shares outstanding | 0m | 0m | 0m | — | — | — | — | — | 7m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$13.8m | −$17.1m | −$14.1m | −$10.6m | −$13.5m | −$7.3m | −$3.6m | −$716,385 | −$112,197 |
| Capital spending | −$18,175 | −$4,188 | −$3,901 | −$4,422 | −$5,748 | −$17,945 | −$20,120 | −$5 | −$3 |
| Free cash flow | −$13.8m | −$17.1m | −$14.1m | −$10.6m | −$13.5m | −$7.3m | −$3.6m | −$716,390 | −$112,200 |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $3,140 | $3,140 | — |
| Gross profit | — | −$1,868 | $2,898 | −$697 | −$1,101 | −$1,100 | −$985 | −$751 |
| Operating income | −$2.7m | −$5.0m | −$6.0m | −$3.3m | −$2.4m | −$4.3m | −$3.2m | −$5.6m |
| Net income | −$2.6m | −$4.9m | −$6.0m | −$3.2m | −$2.4m | −$4.3m | −$3.2m | −$5.6m |
| Diluted earnings per share | -0.38 | -0.72 | -13.43 | -7.26 | -5.36 | -9.70 | -26.96 | -47.59 |
| Cash from operations | −$3.0m | −$4.0m | −$3.0m | −$2.0m | −$5.0m | −$3.0m | −$5.0m | −$6.0m |
| Total assets | $21.9m | $4.7m | $8.6m | $11.9m | $14.5m | $13.7m | $8.7m | $7.4m |
| Cash and short-term investments | $20.0m | $3.0m | $7.2m | $9.9m | $12.1m | $13.0m | $6.5m | $7.0m |
| Debt | — | $232,353 | $328,571 | $30,793 | $121,767 | $210,673 | $326,072 | $31,187 |
| Shareholders' equity | $18.2m | $70,705 | $4.5m | $9.9m | $13.1m | $11.0m | $6.2m | $3.4m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Operating income | 2.3% | 11.1% | — |
| Net income | 1.2% | 10.9% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Price to earnings | -0.1 | -0.2 | -0.2 | -1408.6 | -13024.8 | -50615.8 | -271035.9 |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Return | -65% | -99% | -56% | -89% | -64% | -34% | -18% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 12-to-1 reverse split · 22 Jul 2025
- 50-to-1 reverse split · 21 Feb 2025
- 50-to-1 reverse split · 5 Jun 2024
- 30-to-1 reverse split · 29 Nov 2022
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.